{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T11:49:17Z","timestamp":1751629757905},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2015,4,17]],"date-time":"2015-04-17T00:00:00Z","timestamp":1429228800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1007\/s11255-015-0970-8","type":"journal-article","created":{"date-parts":[[2015,4,16]],"date-time":"2015-04-16T06:12:08Z","timestamp":1429164728000},"page":"837-845","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Risk-based individualisation of target haemoglobin in haemodialysis patients with renal anaemia in the post-TREAT era: theoretical attitudes versus actual practice patterns (MONITOR-CKD5 study)"],"prefix":"10.1007","volume":"47","author":[{"given":"Loreto","family":"Gesualdo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Combe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian","family":"Covic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Dellanna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Goldsmith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00e9rard","family":"London","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes F.","family":"Mann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Zaoui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Turner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mike","family":"Muenzberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"MacDonald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivo","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,4,17]]},"reference":[{"key":"970_CR1","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1001\/archinte.162.12.1401","volume":"162","author":"BC Astor","year":"2002","unstructured":"Astor BC, Muntner P, Levin A et al (2002) Association of kidney function with anemia: the Third National Health and Nutrition Examination Survey (1988\u20131994). Arch Intern Med 162:1401\u20131408","journal-title":"Arch Intern Med"},{"key":"970_CR2","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/kisup.2012.37","volume":"2","author":"KDIGO","year":"2012","unstructured":"KDIGO (2012) KDIGO clinical practice guideline for anemia in chronic kidney disease. Kidney Int Suppl 2:279\u2013335","journal-title":"Kidney Int Suppl"},{"key":"970_CR3","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1093\/ndt\/gfn653","volume":"24","author":"F Locatelli","year":"2009","unstructured":"Locatelli F, Covic A, Eckardt KU et al (2009) Anaemia management in patients with chronic kidney disease: a position statement by the Anaemia Working Group of European Renal Best Practice (ERBP). Nephrol Dial Transplant 24:348\u2013354","journal-title":"Nephrol Dial Transplant"},{"key":"970_CR4","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1056\/NEJMoa0907845","volume":"361","author":"M Pfeffer","year":"2009","unstructured":"Pfeffer M, Burdmann EA, Chen CY et al (2009) A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med 361:2019\u20132032","journal-title":"N Engl J Med"},{"key":"970_CR5","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1517\/14740338.2012.712680","volume":"11","author":"L Vecchio Del","year":"2012","unstructured":"Del Vecchio L, Locatelli F (2012) Safety issues related to erythropoiesis-stimulating agents used to treat anemia in patients with chronic kidney disease. Expert Opin Drug Saf 11:923\u2013931","journal-title":"Expert Opin Drug Saf"},{"key":"970_CR6","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1161\/CIRCULATIONAHA.111.030411","volume":"124","author":"H Skali","year":"2011","unstructured":"Skali H, Parving HH, Parfrey PS et al (2011) Stroke in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia treated with darbepoetin alfa: the Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT) experience. Circulation 124:2903\u20132908","journal-title":"Circulation"},{"key":"970_CR7","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1517\/14740338.2012.726611","volume":"11","author":"I Abraham","year":"2012","unstructured":"Abraham I, MacDonald K (2012) Safety of erythropoiesis-stimulating agents in patients with end-stage kidney disease: data are safer than extrapolations. Expert Opin Drug Saf 11:885\u2013887","journal-title":"Expert Opin Drug Saf"},{"key":"970_CR8","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s11739-011-0622-7","volume":"8","author":"L Gesualdo","year":"2013","unstructured":"Gesualdo L, London G, Turner M et al (2013) A pharmacoepidemiological study of the multi-level determinants, predictors, and clinical outcomes of biosimilar epoetin alfa for renal anaemia in haemodialysis patients: background and methodology of the MONITOR-CKD5 study. Intern Emerg Med 8:389\u2013399","journal-title":"Intern Emerg Med"},{"key":"970_CR9","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1086\/225231","volume":"77","author":"DI Phillips","year":"1972","unstructured":"Phillips DI, Clancy KJ (1972) Some effects of \u2018social desirability\u2019 in survey studies. Am J Sociol 77:921\u2013940","journal-title":"Am J Sociol"},{"key":"970_CR10","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1093\/ndt\/gft033","volume":"28","author":"F Locatelli","year":"2013","unstructured":"Locatelli F, B\u00e1r\u00e1ny P, Covic A et al (2013) Kidney Disease: Improving Global Outcomes guidelines on anaemia management in chronic kidney disease: a European Renal Best Practice position statement. Nephrol Dial Transplant 28:1346\u20131359","journal-title":"Nephrol Dial Transplant"},{"key":"970_CR11","unstructured":"von Gersdorff G, Vega O, Schaller M et al (2011) Influence of age on anemia management: differences and commonalities between cohorts from a US and German registry. Abstract\/poster from the XLVIII ERA-EDTA Congress, Prague, Czech Republic, June 23\u201326 2011. http:\/\/www.abstracts2view.com\/era_archive\/view.php?nu=ERA11L_1674 . Accessed 21 Feb 2014"},{"key":"970_CR12","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1053\/j.ajkd.2012.10.002","volume":"61","author":"D Fuller","year":"2013","unstructured":"Fuller D, Pisoni RL, Bieber BA et al (2013) The DOPPS practice monitor for US dialysis care: trends through December 2011. Am J Kidney Dis 61:342\u2013346","journal-title":"Am J Kidney Dis"},{"key":"970_CR13","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1093\/ndt\/gft062","volume":"10","author":"GR Bailie","year":"2013","unstructured":"Bailie GR, Larkina M, Goodkin DA et al (2013) Variation in intravenous iron use internationally and over time: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 10:2570\u20132579","journal-title":"Nephrol Dial Transplant"},{"key":"970_CR14","first-page":"380","volume":"72","author":"M Haag-Weber","year":"2009","unstructured":"Haag-Weber M, Vetter A, Thyroff-Friesinger U et al (2009) Therapeutic equivalence, long-term efficacy and safety of HX575 in the treatment of anemia in chronic renal failure patients receiving hemodialysis. Clin Nephrol 72:380\u2013390","journal-title":"Clin Nephrol"},{"key":"970_CR15","doi-asserted-by":"crossref","first-page":"24","DOI":"10.5414\/CN107440","volume":"78","author":"WH H\u00f6rl","year":"2012","unstructured":"H\u00f6rl WH, Locatelli F, Haag-Weber M et al (2012) Prospective multicenter study of HX575 (biosimilar epoetin-\u03b1) in patients with chronic kidney disease applying a target hemoglobin of 10\u201312\u00a0g\/dl. Clin Nephrol 78:24\u201332","journal-title":"Clin Nephrol"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-015-0970-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11255-015-0970-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-015-0970-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T23:15:13Z","timestamp":1553642113000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11255-015-0970-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,17]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["970"],"URL":"https:\/\/doi.org\/10.1007\/s11255-015-0970-8","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,17]]}}}